
CEPI commits up to US$80m to University of Oxford to develop vaccines
The US$80m strategic partnership of CEPI, which was established in 2016 in the wake of the Ebola virus outbreak in west Africa, the University of...

Neuraxpharm pays US$650m for MS drug commercialisation
Together with a fee of US$12.5m for the launch of the B cell suppressant antibody to treat relapsing/remitting mulitple sclerosis (rMS), the US$140m...

Spexis AG bags money for pivotal Phase III trial
The cash injection of US$2.5m that was led by SPRIM Global Investments (SGI) is urgently needed to finance US commercialisation of the company’s...

Evotec earns US$40m in global licence deal with BMS
Under a potential US$4bn iPSC-based drug discovery partnership in neurodegeneration with Evotec SE, originally signed in 2016 through Celgene,...

Astraveus SAS bags €16.5m in seed financing
The oversubscribed seed round of Astraveus SAS was led by AdBio partners, co-syndicated with M Ventures, Johnson & Johnson Innovation –...

Antibody provides broad protection vs hantaviruses
In rodents, research teams from France, the US, Germany and Sweden showed that the engineered antibody ADI-65534 protected rodents from deadly...

Mithra raises €20m through private placement
Under the terms of the Private Placement, Armistice Capital committed to subscribe for 10 million new shares atz a share price of 2€ per share , of...